Guerbet SA (LON:0ELV)
14.18
+0.42 (3.05%)
Feb 10, 2026, 10:49 AM GMT
Guerbet Revenue
Guerbet had revenue of 394.72M EUR in the half year ending June 30, 2025, with 3.93% growth. This brings the company's revenue in the last twelve months to 820.92M, down -2.36% year-over-year. In the year 2024, Guerbet had annual revenue of 851.12M with 6.97% growth.
Revenue (ttm)
820.92M EUR
Revenue Growth
-2.36%
P/S Ratio
0.22
Revenue / Employee
282.59K EUR
Employees
2,905
Market Cap
153.90M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 851.12M | 55.46M | 6.97% |
| Dec 31, 2023 | 795.65M | 26.16M | 3.40% |
| Dec 31, 2022 | 769.50M | 33.59M | 4.56% |
| Dec 31, 2021 | 735.91M | 19.24M | 2.68% |
| Dec 31, 2020 | 716.67M | -102.33M | -12.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Optima Health | 113.75M |
| Animalcare Group | 81.07M |
| EKF Diagnostics Holdings | 50.22M |
| Tristel | 46.46M |